In TT cells, a NE cancer cell line, TDP-A dose-dependently attenuated BRET from intracellular HDAC1-NanoLuc fusion protein (Figure 1B) in low nanomolar concentrations, where the EC50 was determined to be 6.8nM. Here, HDAC1 is linked to cancer.